SEC Tracker
Get the app

Onconetix ONCO

Onconetix announces reverse stock split

Item 8.01 Other events

Form
8-K
Filed
Importance
Routine
  1. Reverse stock split ratio of 1:10 effective November 6, 2026
  2. Aggregate reverse stock split ratio will be 1:100
  3. Common stock to trade under new CUSIP number
  4. Outstanding shares to decrease from 5.9 million to 589,000

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Onconetix files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Enveric Biosciences ENVB public float $4M, Jun 30, 2025
  2. Polomar Health Services PMHS public float $4M, Jun 30, 2025
  3. Q/C Technologies QCLS public float $4M, Jun 30, 2025
  4. Integrated Biopharma INBP public float $3M, Dec 31, 2025
  5. Jaguar Health JAGX public float $4M, Jun 30, 2025